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s.2013.03Abstract Antimicrobial secondary metabolites from extremophiles play a signiﬁcant role in the
pharmacological industry due to their stable and strong activity and it is used in the treatment of
microbial infections. In the present work, Halomonas salifodinae MPM-TC (M. Peter Marian-T.
Citarasu) was isolated from the solar salt works in India and identiﬁed by 16S rRNA sequencing.
The secondary metabolites were extracted fromH. salifodinaeMPM-TC and tested for antibacterial
activity against aquatic bacterial pathogens such as Vibrio harveyi, Vibrio parahaemolyticus, Pseu-
domonas aeruginosa and Aeromonas hydrophila isolated from infected ﬁsh/shrimp, and it effectively
controlled them with more than 10 mm of zone of inhibition. The metabolites were puriﬁed through
silica column chromatography and in vitro antiviral activity was performed against White Spot Syn-
drome Virus (WSSV) using different fractions. Among the different tested fractions, fraction-III (F-
III) was able to suppress WSSV replication. Shrimps challenged with a WSSV inoculum incubated
with F-III and treated Fenneropenaeus indicus survived around twice as many as the controls. Gas
chromatography–mass spectroscopic (GC–MS) analysis revealed that the antiviral active fraction
contains around eight compounds including Perﬂuorotributylamine, Cyclopentane, 1-butyl-2-ethyl
and 1,10-Biphenyl]-3-amine. Further the active fraction F-III was incorporated in the artiﬁcial diets
at the concentration of 200 (HS1), 400 (HS2) and 800 (HS3) lg kg1 and fed to F. indicus for91 9994273822; fax: +91
T. Citarasu).
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182 S. Velmurugan et al.30 days. After 30 days of culture, shrimps were challenged with virulent WSSV and studied for
WSSV VP 28 gene expression, biochemical, haematological and immunological changes. Surpris-
ingly, groups treated with lower concentrations of fraction F-III (HS1 or HS2) signiﬁcantly
(P< 0.05) suppressed the viral replication. Different levels of protein and glucose, improved total
haemocyte count (THC), coagulase activity and oxyhaemocyanin level all were comparable to con-
trols. Also, immunological parameters such as prophenol oxidase and intracellular superoxide
anion production were signiﬁcantly increased (F= 97.18; P 6 0.001 and F= 5.70; P 6 0.05) in
the groups treated with the three test concentrations. The presence of antiviral and immunostimu-
lant active principles in the F-III fraction effectively suppressed the WSSV load and boosted F. indi-
cus’s immune system. This research will help to develop novel antiviral drugs from plants against
aquatic important pathogens.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Halophilic microbes are found in three domains of life such as
Archaea, Bacteria, Eukarya and adapt to moderate and high
salt concentrations. They grow in the saline range between
3% and 25% NaCl, w/v, but the true halophilic archaea grow
only in extreme saline environments (Litchﬁeld, 2002). Hyper-
saline environments originate by the evaporation of sea water
and are also called thalassic environments (Oren, 2002).
Microbes from marine sources have a rich potential of anti-
microbial active principles (Burgess et al., 1999). Due to the rich
potential bioactive metabolites in the marine microbes, it may be
used as drugs directly or used as lead structures for drug discov-
ery (Proksch et al., 2002). Around 2500 new metabolites
(MNPs) were reported from marine organisms (1977–1987)
ranging from microbes to ﬁsh, which accounts for less than
1% of the total marine organisms. Salt pans are extreme envi-
ronments which inhabit organisms that thrive on high salinities,
temperatures and withstand severe solar radiations. Such organ-
isms are capable of producing interesting metabolites which may
beneﬁt the mankind (Kamat and Kerkar, 2011).
Microbes from salt pans are yet to be fully explored as po-
tential producers of antimicrobial agents. However, few re-
ports are available on the antimicrobial potential of
microorganisms in Indian salterns. Dhanasekaran et al.
(2005) have reported the antibacterial potential of salt pan
actinomycetes from Tamil Nadu, India. Kamat and Kerkar
(2004) have carried out studies on a marine salt pan bacterium,
producing a broad spectrum of antibiotic, from Goa, India.
Pharmacological activities including antibacterial, antiviral,
antifungal, anticoagulant, cardiatonic and antitumour were
well understood from the marine microbial metabolites
(Molinski, 1993) and it will help developing novel drugs
(Bernan et al., 1997).
The killer pathogen, White Spot Syndrome Virus (WSSV) is
causing high mortalities and severe damages leading to heavy
economical losses in the shrimp aquaculture industry. Once
there is a disease outbreak in the cultured shrimps, all shrimps
will succumb to death within 3–10 days (Lightner, 1996). The
methods of current disease treatment against WSSV are cost
effective, less effective and are creating so many undesirable
side effects (Citarasu et al., 2006). Even though antibiotics
and synthetic drugs are giving positive effects, they cannot
be recommended due to their residual effects, resistant strain
development and other environmental hazards (Citarasu,
2010). In order to consider the health and environmental issuesagainst WSSV infection, the culture management should be fo-
cused on environmentally safer methods such as developing
novel antimicrobial secondary metabolite drugs of halophilic
origin. The current research work focuses on controlling
WSSV at in vitro and in vivo levels by delivering antiviral sec-
ondary metabolites isolated from Halomonas salifodinae.
2. Material and methods
2.1. Bacterial sampling and phenotypic identiﬁcation
Condenser sample with salinity of 230& collected from the
Thamaraikulam solar salt works (Lat. 8 110 N and Long.
77 290 E), Kanyakumari district, Tamil Nadu, India. Water
samples were serially diluted from 101 to 108 in sterile saline
water and 100 ll of each dilution was spread onto sterile Hal-
ophilic Agar plates (Hi Media, India). The plates were incu-
bated at 37 C until the colony grows. The dominant pink
colonies were identiﬁed by morphology, physiology and bio-
chemical conﬁrmations following Holt et al. (1994).
2.2. Identiﬁcation at genomic level by 16S rRNA sequencing
One hundred nano grams of genomic DNA was extracted in
the dominant bacterial colony and the 16S rRNA gene was
ampliﬁed using the universal primer with the standard PCR
protocol. The PCR products were puriﬁed by a Gel extraction
kit (Medox Biotech India Pvt. Ltd) and sequenced (Chromos
Biotech Pvt. Ltd, Bangalore). The nucleotides of the 16S
rRNA sequence were matched with the other microbes in the
NCBI database using the BLAST program. The construction
of phylogenetic tree was carried out by Geneious Basic soft-
ware and evolutionary history inferred using the neighbour-
joining method (Sneath and Sokal, 1973).
2.3. Extraction of antimicrobial secondary metabolites
The strain H. salifodinae MPM-TC was inoculated in halo-
philic broth (Hi Media, India) and incubated for 7 days in a
shaker (2000 g) at 37 C. The bacterial culture after incubation
was spun at 5000 g for 30 min and the supernatant ﬁltered
through a 0.22 lm membrane ﬁlter. The ﬁltrates were ex-
tracted with the equal volume of ethyl acetate. Extraction pro-
cess was repeated for four times and then the extract was
concentrated in a rotary evaporator and lyophilized. The crude
extracts were stored at 4 C.
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In vitro antibacterial activity was performed by the extracted
metabolites against aquatic bacterial pathogens (Vibrio har-
veyi, Vibrio parahaemolyticus, Pseudomonas aeruginosa and
Aeromonas hydrophila) using agar diffusion following the
method of Baur et al. (1966).
2.5. Puriﬁcation of antimicrobial secondary metabolites
The preparative silica column chromatography was used to
purify the crude metabolites (50–80 lm particle size; 30 cm col-
umn length; 0.5 ml elution ﬂow rate and three bed volume elu-
tion). Different proportions of the mobile phases such as
hexane/ethyl acetate and ethyl acetate/methanol were used
for eluting the active compounds. The different eluates were
collected, concentrated in a rotary evaporator and stored at
4 C. The fractions were spotted on silica gel plates GF254
(Merck), 20 · 20 cm, 1 mm thick and the chromatogram was
developed using, hexane: ethyl acetate (8:2) as mobile phase.
The plates were visualized under short UV wavelength.
2.6. Determination of antiviral activity
Shrimps infected with WSSV with prominent white spots were
collected from the intensive shrimp farm located near Nellore,
Andhra Pradesh, India. The infected shrimp Penaeus monodon
were bled, the haemolymph samples pooled and spun at 3000
g for 20 min at 4 C. Then the supernatant was re-spun by
8000 g for 30 min at 4 C and the supernatant was ﬁltered by
0.22 lm membrane ﬁlters for isolating WSSV particles. This
supernatant contains a high quantity of WSSV particles. After
protein quantiﬁcation (Lowry et al., 1951), isolated WSSV was
stored at 20 C for further studies. Also, 1000 lg of puriﬁed
metabolite fractions (FI–V) were dissolved in 1000 ll of NTE
buffer (0.2 M of NaCl, 0.02 M of Tris–HCl and 0.02 M of
EDTA and adjusted to pH 7.4) as stock for further bioassay
studies. A puriﬁed WSSV suspension (10 ll) was mixed with
10 ll ofH. salifodinaeMPM-TC secondary metabolite fractions,
independently and incubated at 29 C for 3 h in a thermostat
incubator. After 3 h, 10 ll of the mixture was injected intramus-
cularly into the second abdominal segment of Fenneropenaeus
indicus (weight = 8.0 ± 1 g). Mortalities were recorded daily
in a day up to 10 days after challenge. Control shrimps were also
maintained as described for the animals treated with the frac-
tions. The haemolymph samples were collected from the chal-
lenged shrimps, extracted for genomic DNA and WSSV
diagnostic PCR performed (Takahashi et al., 1996).
2.7. Structural characterization of the active fractions
Based on the initial screening results, the fraction III (H-6;EA-
4), had higher antiviral activity against WSSV. The same frac-
tion was used for the structural characterization by Gas Chro-
matography–Mass Spectroscopy (GC–MS) analysis. GC–MS
was performed with a machine HP5890 model and a column
Rtx-502.20 was used. The column size was 60 m, 0.25 mm,
1.4 lm. Flow rate was (Helium) 1 ml/min and the temperature
of injector was 250 C. Mass spectra were recorded for a mass
range of 40–550 amu. NIST 98 library software was used for
identifying compounds.2.8. Experimental diet preparation
Ingredients and formulation of the basal diet were described
by Boonyaratpalin (1993). H. salifodinae secondary metabo-
lites were incorporated to artiﬁcial diets at the concentration
of 200 (HS1), 400 (HS2), and 800 (HS3) lg kg1. Control diet
(C), was also prepared devoid of metabolites. The basal feed
ingredients were thoroughly mixed with 4% gelatin solution
containing appropriate concentration of secondary metabo-
lites along with oil ingredients. In order to adjust the pH
(7 ± 0.1), saturated sodium hydroxide solution was added to
the ingredients and mixed thoroughly for 15 min. After that,
the dough was extruded by a pelletiser to needed size, air dried
and stored in air tight containers.
2.9. Culture set-up and WSSV challenge
WSSV free F. indicus (8.2 ± 1 g) were collected from the Man-
akudy estuary of Tamilnadu, India. They were acclimatized to
laboratory conditions and transferred into individual experi-
mental ﬁbre glass tanks (1000 l capacity) with continuous
ﬂow-through water and constant aeration. Each treatment and
control groups was done in triplicate (n= 50 · 3 = 150). Water
quality parameters such as temperature (27 ± 1.0 C), salinity
(28 ± 1.5&), and pH (8.2 ± 0.1) were monitored daily. The
shrimps were fed three times a day at 8.00, 13.00 and 18.00 h
at 10% of the mean body weight. After 30 days of feeding exper-
iment, 100 shrimps from each experimental groups and control
were injected intramuscularly with a WSSV ﬁltrate prepared
from infected shrimps (30 lg of total protein per animal) in
the second abdominal segment. Meanwhile, 10 shrimps from
each group were similarly injected with 0.01 ml saline per shrimp
as the control ‘blank group’. The percentage of cumulative mor-
tality was monitored at least for 10 days after challenge
2.10. Molecular diagnosis of WSSV
Haemolymph samples collected from both the experimental
and control groups were checked for WSSV infection using a
nested PCR using the primers designed by Takahashi et al.
(1996). The DNA extraction and PCR ampliﬁcation were car-
ried out by following the method described by Chang et al.
(1999). Haemolymph samples from treatment and control
shrimps were tested by the ﬁrst step PCR. The negative sam-
ples detected in the ﬁrst step were further subjected to second
step PCR analysis. In each group, 10 surviving shrimp samples
were individually tested.
2.11. Biochemical and haematological changes
Total protein (Lowry et al., 1951) and glucose levels (Malik
and Singh, 1980), were analysed in haemolymph samples of
all groups after WSSV challenge.
Capillary method was adopted to determine the coagula-
tion time of the haemolymph (Sachdev, 1983). Burker haemo-
cytometer was used to count the Total Haemocyte Count
(THC) (cells ml1) from the haemolymph (Le Moullac et al.,
1997). For measuring oxyhaemocyanin, 100 ll of haemolymph
was mixed with 900 ll of distilled water in a 10-mm quartz
cuvette. The absorbance was measured at 335 nm using a
Hitachi U-2000 spectrophotometer (Hitachi, Tokyo, Japan).
184 S. Velmurugan et al.In order to assess the concentration, extinction coefﬁcient
(EmM (1 cm)) of 17.26, was calculated from E1%
(1 cm) = 2.83 (Nickerson and van Holde, 1971) on the basis
of a functional subunit of 74,000 (Antonini and Brunori,
1974; Hagerman,1983).
2.12. Immunological parameters
Phenol oxidase activity in haemolymh was determined using L-
dihydroxyphenylanine (L-DOPA) as a substrate (So¨derha¨ll,
1983). Superoxide anion production was quantiﬁed following
the method of Song and Hsieh (1994). One hundred micro litres
of haemolymph from each groups was centrifuged at 800 g for
5 min and the pellets washed three times with HBSS. Further
the haemocytes were stained with NBT solution (0.3%,
100 ml) for 30 min at 37 C. The reaction was terminated by
adding absolute methanol and washed with 70% methanol for
three times. After drying, 120 ml of 2-M KOH and 140 ml of
DMSO were added into the haemocytes for dissolving the cyto-
plasmic formazan. Dissolved formazan was read at 630 nm on
the generation of O2 in all the tested and control groups.
2.13. Statistical analysis
One way and Two way Analysis of Variance (ANOVA) were
carried out using SPSS statistics data package and Ky plot
respectively. Means were compared at 0.05 and 0.001% levels
for One way ANOVA and Two way ANOVA respectively.
3. Results
3.1. Identiﬁcation of H. salifodinae
The phenotypic conﬁrmation such as morphological, biochemical
and physiological tests revealed that H. salifodinae MPM-TCTable 1 Phenotypic identiﬁcation of H. salifodinae MPM-TC
isolated from solar salt works in comparison with other H.
salifodinae sp. *(Wang et al., 2008).
Sl. No. Test H. salifodinae
MPM-TC
H. salifodinae*
1 Gram staining Negative Negative
2 Cell shape Rods Long rods
3 NaCl concentration 15% 0–20%
4 Motility Motile Motile
5 Indole Negative Negative
6 Methyl red Negative Positive
7 VP Positive Positive
8 Citrate Positive Positive
9 Oxidase Positive Positive
10 Catalase Positive Positive
11 Nitrate Positive Negative
12 Urease Positive Positive
13 Gelatin hydrolysis Positive Negative
14 Starch hydrolysis Positive Positive
15 CHO fermentation Glucose Positive Positive
Sucrose Positive Positive
Galactose Negative Negative
Lactose Positive Negative
* Reference strain.was very similar to H. salifodinae sp. The MPM-TC strain is
motile, with gram negative rods that grow well in 15% NaCl
concentration in the growth media (Table 1). Phylogenetic
and evolutionary analysis of the 16S rRNA sequence revealed
that, H. salifodinae shared more than 90% similarity to other
Halomonas sp. such as Himantura paciﬁca PL51; Halomonas
sp. MML1959 and FIB 29–19 (Fig. 1). The sequence was
deposited in NCBI database and strain name and GenBank
accession number were H. salifodinae MPM-TC; JQ315254.1.
3.2. In vitro antibacterial screening
In vitro antibacterial screening results of the H. salifodinae
MPM-TC antimicrobial secondary metabolites against bacte-
rial aquatic pathogens are presented in Table 2. Secondary
metabolites effectively suppressed the different bacterial
pathogens such as A. hydrophila, V. parahaemolyticus, V. har-
veyi and P. aeruginosa with inhibition zones of 17.11, 16.06,
15.5 and 14 mm, respectively.
3.3. Antiviral screening with puriﬁed H. salifodinae secondary
metabolites fractions
A 100% mortality was observed in F. indicus injected with
WSSV alone and WSSV incubated H. salifodinae MPM-TC
antiviral secondary metabolite fraction F I. 80% cumulative
mortality was observed in F II and F V fractions respectively
and 70% mortality observed in F IV treated F. indicus. Sur-
prisingly, the FIII treated F. indicus achieved only 30% cumu-
lative mortality after 10 days of WSSV challenge. This was the
lowest percentage of cumulative mortality among the different
fractions treated F. indicus due to the antiviral principles. Two
way ANOVA revealed that, the values are signiﬁcantly differ-
ent from each other (F= 19.48; P 6 0.001) (Fig. 2).Figure 1 Phylogenetic relationship of H. salifodinae MPM-TC
with other Halomonas sp. by neighbour joining method con-
structed by Geneious software analysis.
Table 2 In vitro antibacterial activity of antimicrobial sec-
ondary metabolites extracted from H. salifodinae MPM-TC.
Sl. No. Bacterial pathogens Antibacterial activity
(mm of zone of inhibition)
1 V. harveyi 15.5 ± 0.43
2 V. parahaemolyticus 16.06 ± 0.18
3 P. aeruginosa 14.10 ± 0.52
4 A. hydrophila 17.11 ± 0.33
Figure 2 Cumulative mortality of F. indicus injected with WSSV
incubated partially puriﬁed fractions of antiviral secondary
metabolites of H. salifodinae MPM-TC. The values signiﬁcantly
differed from each other (F= 19.48; P 6 0.001) – Two Way
ANOVA.
Figure 3 Percentage PCR detection of F. indicus fed with
antiviral secondary metabolites of H. salifodinae MPM-TC
incorporated diets after challenged with WSSV. Means with the
same superscripts (a–d) do not differ from each other (P< 0.05) –
One Way ANOVA; *n= 20; **n= 12.
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metabolites
The elution of F-III by 60% hexane and 40% ethyl acetate
through the silica column chromatography revealed that the
compounds may have mild polar properties. The higher intensity
peaks and their quality in F-III showed that the compounds are
Perﬂurotributylamine (43%), Cyclopentane, 1-butyl-2-ethyl-
(60%), 1,1’-Biphenyl]-3-amine (27%), Pyridine, 4-(phenyl-
methyl)- (45%), Hexadecane (25%), 2-methyl-, Nonadecane
(35%) and Phytol (74%) by GC–MS analysis (Table 3).
3.5. Inﬂuence of antiviral secondary metabolites on F. indicus
3.5.1. Molecular diagnosis by the expression VP 28 gene
There is no PCR positive signals observed in the blank control
whereas the control group had 100% PCR positive by ﬁrst andTable 3 Major compounds identiﬁed from the secondary metabolit
Sl. no. Retention time Name of the compounds
1 17.15 Perﬂuorotributylamine
2 19.33 Cyclopentane, 1-butyl-2-ethyl-
3 20.24 1,10-Biphenyl]-3-amine
4 20.52 Pyridine, 4-(phenylmethyl)-
5 21.84 Hexadecane, 2-methyl-
6 25.03 Nonadecane
7 25.30 Phytolsecond step detection. A strong PCR ampliﬁcation was ob-
served in shrimps fed with the HS1 diet. The WSSV PCR sig-
nal weakened in HS2 and no WSSV ampliﬁcation was
observed in shrimps treated with the HS3 feed. This may be
due to the increasing concentrations of antiviral secondary
metabolites. In HS1 group, among the tested individual
shrimps 40% were PCR positive during ﬁrst step detection,
25% positive in second step detection and 65% positive in
overall detection after WSSV challenge. Shrimps treated with
HS2 showed no WSSV-positive signal after ﬁrst step PCR
but 12% were WSSV-positive after second and overall PCR
step. None of the shrimps treated with HS3 were detected
WSSV-positive after second step PCR ampliﬁcation. The num-
ber of WSSV-positive animals was signiﬁcantly different
(P< 0.05) among the groups (Fig. 3).
3.5.2. Biochemical and haematological characterization
Total protein value was 113.56 lg ml1 in haemolymph of the
blank control. Total protein value in control shrimps after WSSV
challenge increased signiﬁcantly (P< 0.05) to 121.1 lg ml1 due
to enrichedWSSV load. Further the protein level signiﬁcantly de-
creased to (P< 0.05) 118.1 and 115 lg ml1 in HS1 and HS2
groups respectively from the control group. The H. salifodinae
MPM-TC antiviral secondary metabolites probably helped to
reduce the WSSV load levels in the experimental treatments
which were reﬂected by a decrease of the total protein levels.
The lowest glucose level of 99.2 lg ml1 was observed in thees of H. salifodinae MPM-TC by GC–MS analysis.
Molecular formula Molecular weight Quality (%)
C12F27N 671.5209 43
C11H22 154.2924 60
C12H11N 169.224 27
C12H11N 169.224 45
C17H36 240.4677 25
C19H40 268.5209 35
C20H40O 296.5310 74
Table 4 Biochemical and haematological changes in the haemolymph of F. indicus fed with H. salifodinae incorporated diets after
30th day of WSSV challenge. Means with the same superscripts (a–c) do not differ from each other (P< 0.05) – One Way ANOVA.
Treatments Biochemical parameters Haematological parameters
Protein (lg/ml) Glucose (lg/ml) Total Haemocyte
(·106 cells ml1)
Coagulase activity (S) Oxyhaemocyanin
(m mol l1)
Blank control 113.56a ± 1.24 105.0a ± 0.81 35.34a ± 1.24 120.0a ± 1.69 1.31a NS ± 0.02
Control 121.1b ± 1.17 99.2b ± 0.72 23.56b ± 1.24 218.43b ± 0.56 0.75a NS ± 0.03
HS1 118.1c ± 0.65 101.0c ± 0.351 27.13c ± 1.63 175.2c ± 0.43 1.43b NS ± 0.04
HS2 115.0d ± 0.4 104.2a ± 0.52 33.0a ± 1.69 130.56d ± 0.49 1.57c NS ± 0.01
HS3 112.0a ± 0.47 109.0d ± 1.24 36.65a ± 1.63 121a ± 1.69 1.61a NS ± 0.02
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101, 104.2 and 109 lg ml1 in HS1, HS2 and HS3 groups,
respectively (Table 4).
Control shrimp F. indicus had a total haemocyte count
(THC) of 35.34 · 106 cells ml1. The THC drastically de-
creased to 23.56 · 106 cells ml1 in the control group and this
was increased signiﬁcantly (P< 0.05) by HS1, HS2 and HS3
of 27.13, 33 and 36.65 · 106 cells ml1, respectively. Haemo-
lymph took 218.43 s for coagulation after WSSV challengeFigure 4 a and b Immunological improvement, Phenol Oxidase
(a-top) and Superoxide anion production (b-lower) of F. indicus
fed with antiviral secondary metabolites of H. salifodinae MPM-
TC incorporated diets after challenged with WSSV. The values
signiﬁcantly differed from each others (F= 97.18; P 6 0.001 –
Fig. 6a) and (F= 5.70; P 6 0.05 – Fig. 6b) – Two Way ANOVA.when no antiviral secondary metabolite was given. In contrast,
coagulation time signiﬁcantly (P< 0.05) decreased to 175, 130
and 121 s in the HS1, HS2 and HS3 groups, respectively. The
lowest oxyhaemocyanin level (0.75 mmol l1) was measured in
shrimp fed without antiviral secondary metabolite incorpo-
rated diet. The levels of oxyhaemocyanin increased to 1.43,
1.57 and 1.61 mmol l1 in HS1, HS2 and HS3 groups, respec-
tively (Table 4). The values were not statistically different to
those of control (P> 0.05).
3.5.3. Immunological improvement
The prophenol oxidase activity (pro PO) was higher in animals
treated with HS3 (1.074 after 240 min) whereas the control
group had only an activity of 0.164. Groups HS1 and HS2
showed an increase in the PO activity compared to the control
(0.44 and 0.71 vs. 0.164, respectively). Two-way ANOVA re-
vealed that these values were signiﬁcantly different to each
other (F= 97.18; P 6 0.001) (Fig. 4a). The intracellular super-
oxide anion O2 production had a value of 0.02 in the control
group at 4 days post challenge. Treatment groups HS1, HS2
and HS3 showed a signiﬁcant increase (P< 0.0001) to 0.05,
0.079 and 0.81, respectively. Two-way ANOVA showed that
the values were signiﬁcantly different to each other
(F= 5.70; P 6 0.05) (Fig. 4b).4. Discussion
Nowadays antibiotic resistance is a serious problem in micro-
bial control and the microbes are developing resistance against
commercial antibiotics. The rate of discovery of new
compounds from the terrestrial microbes is declining when
compared with the rate of discovery of new secondary metab-
olites from the microbes of marine and halophilic origin. In the
present study, secondary metabolites of H. salifodinae MPM-
TC were able to inhibit the bacterial growth, suppress the
WSSV multiplication and boost the immune system in F. indi-
cus against the WSSV infection. The results of the present
study showed that metabolites from H. salifodinae MPM-TC
are a feasible alternative to commercially banned antibiotics
and also may help to develop new antiviral drugs against
shrimp viruses such as WSSV. Secondary metabolites with var-
ious biological activities can be induced as a result of the com-
plicated marine environment, some of which represent a
valuable resource waiting to be discovered for the treatment
of infectious diseases (Ronica, 2011). Novel microbial prod-
ucts extracted from marine microbes exhibited antibacterial,
antifungal, antiviral, anticoagulant, cardioactive and antitu-
mor properties (Austin, 1989).
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of H. salifodinae MPM-TC were able to inhibit the growth
of aquatic pathogens such as Vibrio sp., P. aeruginosa and
the fresh water aquatic pathogen A. hydrophila as they pro-
duced an inhibition zone of more than 10 mm. Saccharopolys-
pora salina VITSDK4 isolated from salt pan soil of
Marakkanam coast of the Bay of Bengal, India had antimicro-
bial activity against various bacteria and fungi (Suthindhiran
and Kannabiran 2009). Kamat and Kerkar (2004) have re-
ported a halotolerant Acinetobacter sp. from salt pans of
Ribandar, Goa producing antibacterial compound. In our pre-
vious works, the biosurfactants of halophilic Bacillus sp. and
Halomonas sp. isolated from same solar salt works were able
to suppress the growth of pathogenic bacteria as well as fungi
at in vitro levels (Ronica, 2011). Puriﬁed biosurfactants iso-
lated from marine Bacillus circulans exhibited enhanced sur-
face tension and antimicrobial activities (Mukherjee et al.,
2009). Acidic extracts of the molluscs, Cerastoderma edule,
Ruditapes philippinarum, Ostrea edulis, Crepidula fornicata
and Buccinum undatum had antiviral activity against Herpes
simplex virus type 1 (Defer et al., 2009). Aqueous extract of
the mangrove plant Ceriops tagal had anti WSSV activity in
the P. monodon culture (Sudheer et al., 2011).
Secondary metabolite fractions from H. salifodinae MPM-
TC arrest the WSSV transcription and translation that lead
to no viral multiplication and reduced cumulative mortality
in F. indicus. As there was a un-availability of WSSV cell lines
commercially, the crude type of antiviral screening was per-
formed by incubating the WSSV suspension with secondary
metabolites. The cumulative mortality data of F. indicus trea-
ted with different H. salifodinaeMPM-TC metabolite fractions
may have arrested WSSV transcription and translation leading
to inhibition of viral replication which was reﬂected in F. indi-
cus cumulative mortality. Herbal extracts having antiviral and
immunostimulant properties when incubated with WSSV and
injected to the shrimp P. monodon, effectively suppressed the
WSSV and reﬂected in the improved shrimp survival after
WSSV challenge (Citarasu et al., 2006; Balasubramanian
et al., 2008; Yogeeswaran et al., 2012). The PCR detection at
in vivo levels also proved that the WSSV suppression was
signiﬁcant. The increasing concentrations of the F-III
(800 mg kg1) in the diets highly suppressed the viral load at
100% level after second step PCR detection. The F-III, antivi-
ral secondary metabolite fraction of H. salifodinae MPM-TC
contained the active compounds of potent antiviral activities.
This was also supported by Citarasu et al. (2006) who stated
that by treating P. monodon with herbal extracts then challeng-
ing with WSSV had only 25% PCR positive.
GC–MS analysis revealed that, F-III contains the active
compounds of Perﬂurotributylamine, Cyclopentane, 1-butyl-
2-ethyl, 1,10-Biphenyl]-3-amine, Pyridine, 4-(phenylmethyl),
Hexadecane, 2-methyl-, Nonadecane and Phytol. These com-
pounds may be responsible for suppressing the WSSV tran-
scription. Our previous study (Ronica, 2011), also revealed
that the antiviral activity against WSSV using the biosurfac-
tant isolated from halophilic Bacillus sp. BS3 from the same
solar salt works reduced WSSV multiplication. Virmani et al.
(1983) pointed out that, perﬂuorotributylamine (Oxypherol)
inﬂuenced to stimulate the immune functions such as phago-
cytes in rabbit and human blood exposed to in vivo and
in vitro conditions and improve Neutrophil superoxide (O2)
(Virmani et al., 1984). The presence of perﬂuorotributylaminein F III, boosted the immune system in F. indicus leading to an
arrest of the multiplication of WSSV. Cyclopentane and cyclo-
pentene P2-motifs inhibited the hepatitis C virus NS3 protease
(Johansson et al., 2006; Ba¨ck et al., 2007). The FIII also con-
tains Cyclopentane, 1-butyl-343 2-ethyl- at the molecular
weight of 154.29. The presence of this compound in FIII might
contribute to inhibit WSSV at the translational level in vivo.
The derivatives of 3-(40-bromo-[1,10-biphenyl]-4-yl)-3-(4-X-
phenyl)-N,N-dimethyl-2-propen-1-amine (5a–m) had the po-
tent antibacterial activity against M. tuberculosis and other
Mycobacterium sp. (de Souza et al., 2001) and antifungal activ-
ities against Candida albicans, Candida parapsilosis, Criptococ-
cus neoformans, Tricophyton verrucosum, Trichophyton rubrum,
Microsporum gypseum and Aspergillus fumigates (Castellano
et al., 2003). Also pytol had the molecular weight of 296.53
at high quality in the F III able to suppress the multiplication
of WSSV. Pytol and its derivatives were reported as the immu-
nostimulants in mice (Chowdhury and Ghosh, 2012) and act as
antibacterial agents (Inoue et al., 2005). Based on the presence
of immunostimulant, antiviral, antibacterial and antifungal
compounds in the F III, it effectively controlled the WSSV
multiplication.
The H. salifodinae MPM-TC secondary metabolites helped
to decrease the protein level in WSSV challenged F. indicus by
arresting the viral multiplication. Generally high total protein
levels were seen in infected crustaceans due to the huge bacte-
rial or viral loads and the heavy load reﬂects the increased pro-
tein content. The delivery of antiviral or immunostimulant
compounds may help to decrease the load after infection (Cit-
arasu et al., 2006). The total protein level observed was
121.1 lg ml1 in the control group. In this study, the experi-
mental groups helped to decrease the load signiﬁcantly from
the control group due the presence of antiviral compounds.
The compounds might have suppressed the transcription and
translation of WSSV that lead to the failure of multiplication
and effected as decreased protein level. Earlier study by Citar-
asu et al. (2006) proved that the delivery of plant antiviral/
immunostimulant extracts when treated to infected shrimp
showed a reduced protein level. Manduca sexta larvae infected
with polydnavirus had abundant viral protein in the haemo-
lymph as reported by Harwood et al. (1994). Sahul Hameed
et al. (1998) supported that, there was a higher WSSV viral
protein level observed by the western blot analysis in different
tissues and haemolymph of the WSSV infected shrimp. PCR
analysis revealed that there is a presence of high concentration
of WSSV in the haemolymph of infected shrimp (Lo et al.,
1997). Herbal immunostimulants along with inactivated
WSSV vaccines also helped to decrease the protein level in in-
fected P. monodon leading to arrest of the WSSV multiplica-
tion (Yogeeswaran et al., 2012). Stressed or infected animals
had found high levels of glucose and total carbohydrate in hae-
molymph. This is due to the transportation of glucose and car-
bohydrate from hepatopancreas and muscle to haemolymph
(Yoganandhan et al., 2002). The present study showed the low-
est glucose level (99.2 lg ml1) in the control group and this
parameter signiﬁcantly increased in the HS3 treated group
(109.0 lg ml1).
The heavy WSSV load in haemolymph affected haemato-
logical parameters such as reduced THC, prolonged coagula-
tion time and reduced oxyhaemocyanin levels (Citarasu
et al., 2006). This was reﬂected in the present work with the
values of 23.56 · 106 cells ml1 (THC), 218.43 s of coagulation
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group, respectively. The groups treated with antiviral second-
ary metabolites showed an increase in THC and oxyhaemocy-
anin levels and a reduction in coagulation time. Coagulation
time and THC signiﬁcantly differed between F. indicus infected
with WSSV and those un- infected (Yoganandhan et al., 2002).
Total haemocyte count was found to decrease in shrimp in-
fected with a penaeid rod-shaped DNA virus (Maeda et al.,
1997). Ratcliffe and Rowley (1979) and Sahul Hameed
(1989) reported that, a decline in the level of THC in infected
shrimps is due to the accumulation of haemocytes on the injec-
tion site for wound healing and phagocytosis of foreign bodies.
Budding of the virus or virus induced apoptosis is also respon-
sible for declining THC during viral infections (Cohen, 1993).
Hagerman (1986) reported that, moulting cycle, nutritional
and stress conditions affected the haemocyanin levels. The de-
creased level of oxyhaemocyanin was observed when F. indicus
was devoid of antiviral secondary metabolite treatment and it
was increased by the delivery of metabolites. It is concluded
that, the H. salifodinae MPM-TC secondary metabolites
helped to recover from the infections and improved the haema-
tological parameters.
In the present experiment, proPO activity and O2 produc-
tion were higher in the experimental groups when compared
to the control and those parameters seem to act as stimulators
of shrimp immune system against the WSSV infection. Johans-
son et al. (2000) described that, phagocytosis, nodule forma-
tion, encapsulation, and haemocyte locomotion were
activated by the proPO activating system. Song and Hsieh
(1994) pointed out that, the increased disease resistance re-
sponse is by production of extra bactericidal substances, such
as H2O2 and superoxide anion (O

2 ) from activated haemo-
cytes. Both activities were observed at the decreased level when
devoid of H. salifodinae MPM-TC antiviral secondary metab-
olite delivery. It was gradually increased with the increasing
concentrations of metabolites in the diets. Phenoloxidase
(PO) activity was signiﬁcantly (P< 0.05) enhanced in black ti-
ger shrimp haemolymph treated with Brewer’s yeast b-glucans
compared with control shrimp (Suphantharika et al., 2003).
Takahashi et al. (2000) found that boosted proPO activating
system helps to control the virus by oral administration of
LPS. P. monodon fed with 1–3% polysaccharide gel (PG) sup-
plemented diet achieved higher survival percentage, increased
THC and prophenoloxidase activity against the WSSV chal-
lenge (Pholdaeng and Pongsamart, 2010). Sarlin and Philip
(2011) studied the efﬁcacy of marine yeasts Debaryomyces
hansenii (S8) and Candida tropicalis (S186) to stimulate the im-
mune system in F. indicus against WSSV infection. The second-
ary metabolites of the thermophilic bacteria, Anoxybacillus
kamchatkensis, improved the immunological parameters like
serum SOD, lysozyme, bactericidal activity and phagocytic
activity in common carp, Cyprinus carpio against A. hydrophila
(Wang et al., 2011). P. monodon brooder treated with beta glu-
can for 24 days, helped to improve the relative in vivo intracel-
lular O2 production of haemocytes by 15.7 times. The antiviral
secondary metabolites of H. salifodinaeMPM-TC had the bet-
ter antiviral and immunostimulating effects in F. indicus
against WSSV infection. The ﬁndings of the present study con-
cluded that, the secondary metabolites of H. salifodinaeMPM-
TC were able to suppress the WSSV multiplication at the
in vivo level and boost F. indicus’s immune system against
WSSV infection. This approach will help to develop novelantiviral drugs against ﬁn and shell ﬁsh virus from extremo-
philic source.
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